Physiologic characterization of endothelin A and B receptor activity in the ovine fetal pulmonary circulation.
Open Access
- 1 May 1994
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 93 (5) , 2141-2148
- https://doi.org/10.1172/jci117210
Abstract
To determine the potential contribution of endothelin (ET) to modulation of high pulmonary vascular resistance in the normal fetus, we studied the effects of BQ 123, a selective ET-A receptor antagonist, and sarafoxotoxin S6c (SFX), a selective ET-B receptor agonist, in 31 chronically prepared late gestation fetal lambs. Brief intrapulmonary infusions of BQ 123 (0.1-1.0 mcg/min for 10 min) caused sustained increases in left pulmonary artery flow (Qp) without changing main pulmonary artery (MPA) and aortic (Ao) pressures. In contrast, BQ 123 did not change vascular resistance in a regional systemic circulation (the fetal hindlimb). To determine whether big-endothelin-1 (big-ET-1)-induced pulmonary vasoconstriction is mediated by ET-A receptor stimulation, we studied the effects of big-ET-1 with or without pretreatment with BQ 123. BQ 123 (0.5 mcg/min for 10 min) blocked the rise in total pulmonary resistance caused by big-ET-1. CGS 27830 (100 mcg/min for 10 min), an ET-A and -B receptor antagonist, did not change basal tone but blocked big-ET-1-induced pulmonary vasoconstriction. Brief and prolonged intrapulmonary infusion of SFX (0.1 mcg/min for 10 min) increased Qp twofold without changing MPA or Ao pressures. Nitro-L-arginine (L-NA), a selective endothelium-derived nitric oxide (EDNO) antagonist, blocked vasodilation caused by BQ 123 and SFX. We conclude that: (a) BQ 123 causes sustained fetal pulmonary vasodilation, but did not change vascular resistance in the fetal hindlimb; (b) Big-ET-1-induced pulmonary vasoconstriction may be mediated through ET-A receptor stimulation; and (c) ET-B receptor stimulation causes pulmonary vasodilation through EDNO release. These findings support the hypothesis that endothelin may play a role in modulation of high basal pulmonary vascular resistance in the normal fetus.Keywords
This publication has 50 references indexed in Scilit:
- Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial cells.Journal of Clinical Investigation, 1993
- Functionally Distinct Endothelin B Receptors in Vascular Endothelium and Smooth MuscleBiochemical and Biophysical Research Communications, 1993
- Mediation via different receptors of the vasoconstrictor effects of endothelins and sarafotoxins in the systemic circulation and renal vasculature of the anaesthetized ratBritish Journal of Pharmacology, 1993
- Endothelin-1 in primary pulmonary hypertension and the Eisenmenger syndromeThe American Journal of Cardiology, 1993
- Endothelin ETA and ETB receptors mediate vascular smooth muscle contractionBritish Journal of Pharmacology, 1992
- Circulating levels of endothelin and atrial natriuretic factor during postnatal lifeActa Paediatrica, 1992
- Human big‐endothelin‐1 and endothelin‐1 release prostacyclin via the activation of ET1 receptors in the rat perfused lungBritish Journal of Pharmacology, 1992
- In Vitro Biological Profile of a Highly Potent Novel Endothelin (ET) Antagonist BQ-123 Selective for the ETA ReceptorJournal of Cardiovascular Pharmacology, 1992
- Analysis of regional responses to endothelin in hindquarters vascular bed of catsAmerican Journal of Physiology-Heart and Circulatory Physiology, 1989
- Molecular mechanism of action of the vasoconstrictor peptide endothelinBiochemical and Biophysical Research Communications, 1988